Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Neuroone Medical Technologies (NMTC) over the last 12 years, with Q4 2025 value amounting to $706112.0.

  • Neuroone Medical Technologies' Accumulated Expenses fell 1455.42% to $706112.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $706112.0, marking a year-over-year decrease of 1455.42%. This contributed to the annual value of $1.3 million for FY2025, which is 918.06% up from last year.
  • Neuroone Medical Technologies' Accumulated Expenses amounted to $706112.0 in Q4 2025, which was down 1455.42% from $1.3 million recorded in Q3 2025.
  • Neuroone Medical Technologies' 5-year Accumulated Expenses high stood at $1.3 million for Q3 2025, and its period low was $356374.0 during Q4 2021.
  • Its 5-year average for Accumulated Expenses is $723855.6, with a median of $710975.5 in 2022.
  • Per our database at Business Quant, Neuroone Medical Technologies' Accumulated Expenses tumbled by 4175.68% in 2021 and then skyrocketed by 6491.92% in 2023.
  • Quarter analysis of 5 years shows Neuroone Medical Technologies' Accumulated Expenses stood at $356374.0 in 2021, then surged by 32.75% to $473085.0 in 2022, then skyrocketed by 31.74% to $623240.0 in 2023, then soared by 32.6% to $826386.0 in 2024, then dropped by 14.55% to $706112.0 in 2025.
  • Its last three reported values are $706112.0 in Q4 2025, $1.3 million for Q3 2025, and $958056.0 during Q2 2025.